Event Detail (Archived)

Human Skin Microbiome: Finding Friends Amongst the Foes

  • This event already took place in November 2026
  • Caspary Auditorium

Event Details

Type
Friday Lecture Series
Speaker(s)
Julie Segre, Ph.D., professor of microbiology and immunology, Mary Sue Coleman Director, Life Sciences Institute, University of Michigan
Speaker bio(s)

The varied topography of human skin offers a unique opportunity to study how the body’s microenvironments influence the functional and taxonomic composition of microbial communities. However, the paucity of commensal microbial genomes has limited our ability to comprehensively interpret the structure and function of these communities. Dr. Segre's group combined extensive culturing and the development of computational pipelines to create metagenomic assembled genomes to elucidate novel constituents, structure and functions of the human skin microbiome.

Built upon this genomic framework, they explore global diversity of skin microbiomes, including the emerging fungal pathogen Trichophyton concentricum amongst the Orang Asli indigenous people of Malaysia; the spread of multi-drug resistant including C. auris and ESKAPE pathogens amongst residents in long term care facility; and the persistence of bacterial commensal strains from early childhood with implications for infection susceptibility and therapeutic modulation.

Julie Segre, Ph.D. is the Director of the Life Sciences Institute, an interdisciplinary institute established to foster innovation at the University of Michigan. Until recently, Segre for 26 years was an NIH Distinguished Investigator at the National Human Genome Research Institute, NIH Intramural Research Program. Her research focuses on the human microbiome, investigating both the transmission of hospital pathogens and the diversity of commensal skin organisms, including bacteria, fungi and viruses.  Segre’s research integrates DNA sequence technology, algorithm development and clinical studies to explore the diversity of microbes in and on humans in health and disease. Her skin microbiome studies include characterizing variation across body sites to investigate the stereotypic manifestation of cutaneous disorders, such as atopic dermatitis (eczema). New projects expand global skin microbiome studies to Africa and Oceania, investigating the role of the fungi Trichophyton concentraticum in tinea imbricata. Tracking multi-drug resistant organisms in healthcare ecosystems, her current research focuses on the emerging fungal pathogen Candida auris primarily in nursing homes. She is a member of both the National Academy of Sciences and the National Academy of Medicine.

Open to
Tri-Institutional